Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.38
+0.15 (0.98%)
Sep 30, 2026, 1:47 PM EDT - Market open
Cullinan Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +127.57% | Sep 25, 2026 |
| BTIG | BTIG | Buy Reiterates $40 | Buy | Reiterates | $40 | +160.08% | Sep 25, 2026 |
| Wedbush | Wedbush | Buy Reiterates $42 | Buy | Reiterates | $42 | +173.08% | Sep 25, 2026 |
| Citi | Citi | Buy Maintains $33 | Buy | Maintains | $33 | +114.56% | Sep 25, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 24, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 24, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +153.58% | Sep 16, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $30 | Buy | Maintains | $30 | +95.06% | Sep 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.